Although all of the NPM-ALK+ ALCL cell lines used in this study demonstrated significant in vitro responses to ASP3026, some assays showed variable sensitivities of the different cell lines to the effects of ASP3026. The gene discussed is ALK; the disease is anaplastic large cell lymphoma.